tiprankstipranks
Trending News
More News >
Swedish Orphan Biovitrum Ab (SE:SOBI)
:SOBI
Advertisement

Swedish Orphan Biovitrum AB (SOBI) Stock Statistics & Valuation Metrics

Compare
2 Followers

Total Valuation

Swedish Orphan Biovitrum AB has a market cap or net worth of kr94.45B. The enterprise value is kr111.82B.
Market Capkr94.45B
Enterprise Valuekr111.82B

Share Statistics

Swedish Orphan Biovitrum AB has 356,000,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding356,000,060
Owned by Insiders
Owned by Institutions

Financial Efficiency

Swedish Orphan Biovitrum AB’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.40%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)7.40%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee13.73M
Profits Per Employee2.33M
Employee Count1,895
Asset Turnover0.34
Inventory Turnover1.39

Valuation Ratios

The current PE Ratio of Swedish Orphan Biovitrum AB is 21.6. Swedish Orphan Biovitrum AB’s PEG ratio is 0.53.
PE Ratio21.6
PS Ratio4.17
PB Ratio2.69
Price to Fair Value2.69
Price to FCF24.75
Price to Operating Cash Flow14.02
PEG Ratio0.53

Income Statement

In the last 12 months, Swedish Orphan Biovitrum AB had revenue of 26.03B and earned 3.88B in profits. Earnings per share was 11.37.
Revenue26.03B
Gross Profit20.24B
Operating Income5.63B
Pretax Income4.41B
Net Income3.88B
EBITDA9.30B
Earnings Per Share (EPS)11.37

Cash Flow

In the last 12 months, operating cash flow was 6.74B and capital expenditures -2.67B, giving a free cash flow of 4.07B billion.
Operating Cash Flow6.74B
Free Cash Flow4.07B
Free Cash Flow per Share11.43

Dividends & Yields

Swedish Orphan Biovitrum AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.98
52-Week Price Change-0.22%
50-Day Moving Average285.50
200-Day Moving Average302.21
Relative Strength Index (RSI)46.21
Average Volume (3m)277.67K

Important Dates

Swedish Orphan Biovitrum AB upcoming earnings date is Oct 23, 2025, Before Open (Confirmed).
Last Earnings DateJul 16, 2025
Next Earnings DateOct 23, 2025
Ex-Dividend Date

Financial Position

Swedish Orphan Biovitrum AB as a current ratio of 1.04, with Debt / Equity ratio of 32.80%
Current Ratio1.04
Quick Ratio0.71
Debt to Market Cap0.15
Net Debt to EBITDA1.68
Interest Coverage Ratio4.54

Taxes

In the past 12 months, Swedish Orphan Biovitrum AB has paid 528.00M in taxes.
Income Tax528.00M
Effective Tax Rate0.12

Enterprise Valuation

Swedish Orphan Biovitrum AB EV to EBITDA ratio is 13.33, with an EV/FCF ratio of 28.30.
EV to Sales4.77
EV to EBITDA13.33
EV to Free Cash Flow28.30
EV to Operating Cash Flow16.79

Balance Sheet

Swedish Orphan Biovitrum AB has kr1.06B in cash and marketable securities with kr12.81B in debt, giving a net cash position of kr11.76B billion.
Cash & Marketable Securitieskr1.06B
Total Debtkr12.81B
Net Cashkr11.76B
Net Cash Per Sharekr33.02
Tangible Book Value Per Share-kr54.65

Margins

Gross margin is 78.29%, with operating margin of 21.61%, and net profit margin of 14.93%.
Gross Margin78.29%
Operating Margin21.61%
Pretax Margin16.93%
Net Profit Margin14.93%
EBITDA Margin35.75%
EBIT Margin21.61%

Analyst Forecast

The average price target for Swedish Orphan Biovitrum AB is kr341.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Targetkr341.00
Price Target Upside24.00% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast13.75%
EPS Growth Forecast101.18%

Scores

Smart ScoreN/A
AI Score67.8
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis